| Ewing sarcoma TGP Grünewald, F Cidre-Aranaz, D Surdez, EM Tomazou, E de Álava, ... Nature Reviews Disease Primers 4 (1), 1-22, 2018 | 643 | 2018 |
| Sarcoma treatment in the era of molecular medicine TGP Grünewald, M Alonso, S Avnet, A Banito, S Burdach, F Cidre‐Aranaz, ... EMBO molecular medicine 12 (11), e11131, 2020 | 189 | 2020 |
| Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite TGP Grünewald, V Bernard, P Gilardi-Hebenstreit, V Raynal, D Surdez, ... Nature genetics 47 (9), 1073-1078, 2015 | 186 | 2015 |
| EWS/FLI1 target genes and therapeutic opportunities in Ewing sarcoma F Cidre-Aranaz, J Alonso Frontiers in oncology 5, 162, 2015 | 66 | 2015 |
| Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes J Musa, F Cidre-Aranaz, MM Aynaud, MF Orth, MML Knott, O Mirabeau, ... Nature communications 10 (1), 1-10, 2019 | 58* | 2019 |
| The second European interdisciplinary Ewing sarcoma research summit–A joint effort to deconstructing the multiple layers of a complex disease H Kovar, J Amatruda, E Brunet, S Burdach, F Cidre-Aranaz, E De Alava, ... Oncotarget 7 (8), 8613, 2016 | 51 | 2016 |
| Familial retinoblastoma due to intronic LINE-1 insertion causes aberrant and noncanonical mRNA splicing of the RB1 gene C Rodríguez-Martín, F Cidre, A Fernández-Teijeiro, G Gómez-Mariano, ... Journal of human genetics 61 (5), 463-466, 2016 | 48 | 2016 |
| A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas MF Orth, VL Buecklein, E Kampmann, M Subklewe, E Noessner, ... Cancer Immunology, Immunotherapy 69 (7), 1353-1362, 2020 | 44 | 2020 |
| Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells N Agra, F Cidre, L García-García, J de la Parra, J Alonso PloS one 8 (6), 2013 | 44 | 2013 |
| Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma A Marchetto, S Ohmura, MF Orth, MML Knott, MV Colombo, C Arrigoni, ... Nature Communications 11 (1), 1-16, 2020 | 40 | 2020 |
| Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies MML Knott, TLB Hölting, S Ohmura, T Kirchner, F Cidre-Aranaz, ... Cancer and Metastasis Reviews 38 (4), 625-642, 2019 | 39 | 2019 |
| A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling P Altea-Manzano, G Doglioni, Y Liu, AM Cuadros, E Nolan, ... Nature Cancer 4 (3), 344-364, 2023 | 33 | 2023 |
| EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma F Cidre-Aranaz, TGP Grünewald, D Surdez, L García-García, JC Lázaro, ... Oncogene 36 (6), 766-776, 2017 | 32 | 2017 |
| Synthesis and anti-inflammatory activity of ent-kaurene derivatives I Hueso-Falcón, I Cuadrado, F Cidre, JM Amaro-Luis, ÁG Ravelo, ... European journal of medicinal chemistry 46 (4), 1291-1305, 2011 | 32 | 2011 |
| Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients G Sannino, A Marchetto, A Ranft, S Jabar, C Zacherl, R Alba-Rubio, ... EBioMedicine 47, 156-162, 2019 | 28 | 2019 |
| Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma S Ohmura, A Marchetto, MF Orth, J Li, S Jabar, A Ranft, E Vinca, ... Molecular cancer 20 (1), 1-7, 2021 | 26 | 2021 |
| Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma M Dallmayer, J Li, S Ohmura, RA Rubio, MC Baldauf, TLB Hölting, J Musa, ... Cell death & disease 10 (2), 1-13, 2019 | 25 | 2019 |
| Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation MF Orth, D Surdez, T Faehling, AC Ehlers, A Marchetto, S Grossetête, ... Cell Reports 41 (10), 111761, 2022 | 23 | 2022 |
| High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma MF Orth, TLB Hölting, M Dallmayer, FS Wehweck, T Paul, J Musa, ... Cancers 12 (3), 644, 2020 | 21 | 2020 |
| Labdanolic acid methyl ester (LAME) exerts anti-inflammatory effects through inhibition of TAK-1 activation I Cuadrado, F Cidre, S Herranz, A Estevez-Braun, B de las Heras, ... Toxicology and applied pharmacology 258 (1), 109-117, 2012 | 19 | 2012 |
Thomas G. P. GrünewaldHopp-Children´s Cancer Center Heidelberg (KiTZ)Bestätigte E-Mail-Adresse bei kitz-heidelberg.de
